Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree.
Cutter, Gary R
Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree. [electronic resource] - BMC neurology Sep 2016 - 176 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
1471-2377
10.1186/s12883-016-0702-4 doi
Humans
Immunologic Factors--therapeutic use
Multiple Sclerosis, Relapsing-Remitting--drug therapy
Propensity Score
Quinolones--therapeutic use
Randomized Controlled Trials as Topic
Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree. [electronic resource] - BMC neurology Sep 2016 - 176 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
1471-2377
10.1186/s12883-016-0702-4 doi
Humans
Immunologic Factors--therapeutic use
Multiple Sclerosis, Relapsing-Remitting--drug therapy
Propensity Score
Quinolones--therapeutic use
Randomized Controlled Trials as Topic